Powszechny Zaklad Ubezpieczen SA
Powszechny Zaklad Ubezpieczen SA (PWZYF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Powszechny Zaklad Ubezpieczen SA (PWZYF), featuring income statements, balance sheets, and cash flow data.
Powszechny Zaklad Ubezpieczen SA (PWZYF) Income Statement & Financial Overview
Analyze Powszechny Zaklad Ubezpieczen SA’s PWZYF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $16.55B | $14.09B | $13.15B | $15.70B |
| Cost of Revenue | $16.55B | $0.00 | -$2.65B | $0.00 |
| Gross Profit | $0.00 | $14.09B | $15.80B | $15.70B |
| Gross Profit Ratio | $0.00 | $1.00 | $1.20 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $42.00M | $59.00M | $404.00M |
| Operating Expenses | $0.00 | $10.03B | $11.12B | $3.72B |
| Total Costs & Expenses | -$10.33B | $10.03B | $11.12B | -$9.54B |
| Interest Income | $0.00 | $7.31B | $0.00 | $6.95B |
| Interest Expense | $1.75B | $2.07B | $2.04B | $2.05B |
| Depreciation & Amortization | $0.00 | $367.00M | $383.00M | $237.00M |
| EBITDA | $6.07B | $6.50B | $5.84B | $6.38B |
| EBITDA Ratio | $0.37 | $0.46 | $0.44 | $0.41 |
| Operating Income | $6.23B | $4.06B | $5.91B | -$1.63B |
| Operating Income Ratio | $0.38 | $0.29 | $0.45 | -$0.10 |
| Other Income/Expenses (Net) | -$1.91B | $0.00 | -$2.36B | $3.39B |
| Income Before Tax | $4.32B | $4.06B | $3.55B | $3.77B |
| Income Before Tax Ratio | $0.26 | $0.29 | $0.27 | $0.24 |
| Income Tax Expense | $905.00M | $891.00M | $799.00M | $888.00M |
| Net Income | $1.68B | $1.22B | $1.19B | $1.25B |
| Net Income Ratio | $0.10 | $0.09 | $0.09 | $0.08 |
| EPS | $1.95 | $1.41 | $1.38 | $1.45 |
| Diluted EPS | $1.95 | $1.41 | $1.38 | $1.45 |
| Weighted Avg Shares Outstanding | $863.52M | $863.38M | $863.38M | $863.34M |
| Weighted Avg Shares Outstanding (Diluted) | $863.52M | $863.38M | $863.38M | $863.34M |
Financial performance has remained strong, with revenue growing from $15.70B in Q1 2024 to $16.55B in Q4 2024. Gross profit continued to perform well, with margins at N/A in the latest quarter. Operating income reached $6.23B in Q4 2024, holding a steady 38% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $6.07B. Net income rose to $1.68B, keeping EPS at $1.95. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan